My expertise is in allogeneic (donor-provided) blood stem cell transplantation for adult cancer patients. In my laboratory, I investigate the immunological aspects of bone marrow transplantation. My major projects include strategies to enhance post-transplant immune reconstitution; the role of T cells in graft-versus-host-disease, a potentially fatal complication of bone marrow transplants in which immune cells from the donor attack the patient’s tissues; and graft-versus-tumor activity, a beneficial side effect of bone marrow transplants in which donor immune cells attack the patient’s tumor cells.
As a physician-scientist, it is my goal to translate the findings of my laboratory into new therapies that can be evaluated in clinical trials, which could improve the outcome for our transplant patients. Please see the link below for more information about my research activities at the Sloan Kettering Institute.
- Clinical Expertise: Allogeneic Bone Marrow Transplantation
- Languages Spoken: English
- Education: MD, PhD, Leiden University (Netherlands)
- Residencies: Duke University Medical Center
- Fellowships: Beth Israel Deaconess Medical Center
- Board Certifications: Medical Oncology
As home to one of the world’s top cancer research centers, Memorial Sloan Kettering is typically involved in more than 900 clinical trials at a given time. Currently, clinical trials focused on the conditions I treat are enrolling new patients. If you’re interested in joining a clinical trial, click to learn about the trial’s purpose, eligibility criteria, and how to get more information.Learn more
Most major health insurers offer plans that include MSK as one of their in-network providers. If MSK is in-network, it means all our doctors are too. Medicaid and New York State Medicare also provide benefits for care at MSK.Learn more